中药的市场需求稳定，多项政策推动产业升级

Group 1 - A significant number of traditional Chinese medicine (TCM) products are set to exit the market due to unclear safety information regarding adverse reactions, but most of these are "zombie approvals" that have not been sold or produced, thus not affecting the normal supply and market order of TCM [1] - Hong Kong has released its first "Traditional Chinese Medicine Development Blueprint," which covers five key areas: TCM services, TCM professionals, TCM development, cultural inheritance, and global outreach [2] - The blueprint aims to optimize clinical services, establish a cross-professional service system, lead the development of TCM professions, enhance the quality of TCM products, establish international standards for TCM, drive innovation in research and industry, promote TCM culture, and support the global expansion of TCM [2] Group 2 - The Hong Kong government, through the Health Bureau, will actively collaborate with the industry to promote TCM development and implement the recommendations of the blueprint, leveraging Hong Kong's unique position to assist in promoting TCM globally [2] - The market demand for TCM is stable due to the aging population, with the Chinese TCM market expected to exceed 700 billion yuan in 2024, reflecting a year-on-year growth of approximately 6.6% [2] - Recent policies in the TCM industry focus on innovation and high-quality development, with measures such as the establishment of key national laboratories, quality control of pharmaceuticals, and enhanced regulation, leading to a more standardized TCM industry and accelerated resource integration among leading enterprises [2]